4.6 Article

Pleural effusion: a potential surrogate marker for higher-risk patients with acute type B aortic dissections

Journal

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
Volume 61, Issue 4, Pages 816-825

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/ejcts/ezab540

Keywords

Type B aortic dissection; Pleural effusion; Surrogate marker; In-hospital mortality; High-risk patients

Funding

  1. W.L. Gore & Associates, Inc.
  2. Medtronic
  3. Varbedian Aortic Research Fund
  4. Hewlett Foundation
  5. Mardigian Foundation
  6. UM Faculty Group Practice
  7. Terumo
  8. Ann and Bob Aikens

Ask authors/readers for more resources

Pleural effusions occur in around 17.9% of patients with TBAAD, typically in older patients with more comorbidities. The presence of PEff is associated with higher in-hospital mortality, increased rates of complications, and decreased long-term survival. However, PEff is not independently predictive of worse outcomes based on propensity-matched analysis, but may serve as an early surrogate marker for identifying higher-risk patients.
OBJECTIVES: Pleural effusions (PEffs) are known to occur in type B acute aortic dissection (TBAAD). We investigated the relationship between pleural effusion and the development of early or late complications following TBAAD. METHODS: The incidence of PEff (defined as at least an obliteration of the costophrenic angle in a frontal projection) diagnosed on their initial chest X-ray in patients with TBAAD enrolled in the International Registry of Acute Aortic Dissection was examined. We analysed inhospital outcomes and long-term survival separately for patients with and without PEffs (PEff+ versus PEff-, respectively). RESULTS: Included were 1252 patients with TBAAD, of whom 224 (17.9%) had PEff. Compared with patients without PEff in the initial chest X-ray, these were significantly older [mean age 67 (SD: 14.7) vs 63.4 (SD: 14.2) years, P = 0.001] and more often female (42.4% vs 34.2%, P = 0.021) and had more comorbidities (known aortic aneurysm, chronic obstructive pulmonary disease, chronic renal failure, diabetes, congestive heart failure or mitral valve disease). PEff was associated with higher in-hospital mortality (16.1% vs 9.1%, P = 0.002) and increased rates of neurological complications (16.6% vs 11.1%, P = 0.029), acute renal failure (27.2% vs 19.7%, P = 0.017) and hypotension (17.4% vs 9.6%, P = 0.001). In addition, patients with PEff underwent aortic repair more frequently (44.6% vs 32.5%, P < 0.001). In the long-term patients with PEff showed lower 5-year post-discharge survival (67.6% vs 77.6%, P= 0.004). Multivariable analysis with propensity-matched data showed that PEff was not an independent risk factor for in-hospital mortality (odds ratio 1.9, 95% CI 0.8-4.4, P = 0.141). CONCLUSIONS: Patients with TBAAD and evidence of PEff showed a higher in-hospital mortality, are more likely to develop additional in-hospital complications and have a decreased likelihood of survival during follow-up. However, according to propensity-matched analysis, PEff remained not as an independent predictor of worse outcome but might serve as an early surrogate marker to identify higher-risk patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available